ArticleFrontiers in immunology2025

Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors.

Yuhui Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.